2025 Vol.43, N°8 - Table of contents
August - Scleroderma 2025
Review
CER18774
2025,43,8
Pg. 1369-1379
Free to view
Systemic sclerosis: one year in review 2025
M. Di Battista, G. Lepri, V. Codullo, L. Bianchessi, G. Ghezzi, A. Della Rossa, S. Guiducci, F. Del Galdo
DOI: https://doi.org/10.55563/clinexprheumatol/upbjl2
M. Di Battista, G. Lepri, V. Codullo, L. Bianchessi, G. Ghezzi, A. Della Rossa, S. Guiducci, F. Del Galdo
DOI: https://doi.org/10.55563/clinexprheumatol/upbjl2
Environmental Rheumatology
CER18012
2025,43,8
Pg. 1380-1385
Free to view
Primary versus systemic sclerosis-associated Raynaud’s phenomenon: relationship with clinical and environmental factors
E. Favoino, M. Prete, V. Liakouli, A. Sisto, A. Corrado, P. Leone, G. Lisco, M. Vomero, E. Biancalana, E. Chiara, G. Emmi, V. Racanelli, A. Marcoccia, R.D. Grembiale, F.P. Cantatore, L. Navarini, P. Ruscitti, F. Ciccia, R. Giacomelli, F. Perosa
DOI: https://doi.org/10.55563/clinexprheumatol/m7qpn3
E. Favoino, M. Prete, V. Liakouli, A. Sisto, A. Corrado, P. Leone, G. Lisco, M. Vomero, E. Biancalana, E. Chiara, G. Emmi, V. Racanelli, A. Marcoccia, R.D. Grembiale, F.P. Cantatore, L. Navarini, P. Ruscitti, F. Ciccia, R. Giacomelli, F. Perosa
DOI: https://doi.org/10.55563/clinexprheumatol/m7qpn3
Full Papers
CER17986
2025,43,8
Pg. 1386-1390
Free to view
Ultrasound for day-to-day clinical use: construction of a simple discriminator between healthy skin and thickened systemic sclerosis skin
V. Smith, N. Berghen, E. Hysa, A. Vanhaecke, S. Wallaert, E. Gotelli, M. Cutolo
DOI: https://doi.org/10.55563/clinexprheumatol/1c8ikh
V. Smith, N. Berghen, E. Hysa, A. Vanhaecke, S. Wallaert, E. Gotelli, M. Cutolo
DOI: https://doi.org/10.55563/clinexprheumatol/1c8ikh
CER18068
2025,43,8
Pg. 1391-1397
Free to view
Neutrophil gelatinase-associated lipocalin levels are associated with skin thickness and metabolic syndrome features in patients with systemic sclerosis
I. Ferraz-Amaro, S. Castañeda, Z. Ibrahim-Achi, A. De vera-González, M. Renuncio-García, E.F. Vicente-Rabaneda, J.G. Ocejo-Vinyals, M.Á. González-Gay
DOI: https://doi.org/10.55563/clinexprheumatol/lad3qd
I. Ferraz-Amaro, S. Castañeda, Z. Ibrahim-Achi, A. De vera-González, M. Renuncio-García, E.F. Vicente-Rabaneda, J.G. Ocejo-Vinyals, M.Á. González-Gay
DOI: https://doi.org/10.55563/clinexprheumatol/lad3qd
CER18006
2025,43,8
Pg. 1398-1407
Free to view
The effects of interleukin-35 and interleukin-10 on pulmonary inflammation and fibrosis in a bleomycin-induced systemic sclerosis mouse model
Y. Huang, W. Zeng, X. Liao, F. Qin, X. Ma, J. Pan, G. Li, K. Tang, L. Lei
DOI: https://doi.org/10.55563/clinexprheumatol/1t3s0i
Y. Huang, W. Zeng, X. Liao, F. Qin, X. Ma, J. Pan, G. Li, K. Tang, L. Lei
DOI: https://doi.org/10.55563/clinexprheumatol/1t3s0i
CER18066
2025,43,8
Pg. 1408-1413
Free to view
Frailty assessment in patients with systemic sclerosis
C. Barison, E. Piovani, L. Moschetti, E. Pedretti, M.G. Lazzaroni, F. Franceschini, P. Airò
DOI: https://doi.org/10.55563/clinexprheumatol/h04798
C. Barison, E. Piovani, L. Moschetti, E. Pedretti, M.G. Lazzaroni, F. Franceschini, P. Airò
DOI: https://doi.org/10.55563/clinexprheumatol/h04798
CER18156
2025,43,8
Pg. 1414-1421
Free to view
Thymic stromal lymphopoietin in systemic sclerosis interstitial lung disease: a pilot study
C. Pellicano, G. Cusano, A. Colalillo, F. Villani, V. Carnazzo, U. Basile, F. De Filippis, A. Gigante, G. Paone, E. Rosato
DOI: https://doi.org/10.55563/clinexprheumatol/s4m3ax
C. Pellicano, G. Cusano, A. Colalillo, F. Villani, V. Carnazzo, U. Basile, F. De Filippis, A. Gigante, G. Paone, E. Rosato
DOI: https://doi.org/10.55563/clinexprheumatol/s4m3ax
CER18313
2025,43,8
Pg. 1422-1430
Free to view
ADAMTS13 and insulin resistance in systemic sclerosis patients
I. Ferraz-Amaro, Z. Ibrahim-Achi, A. De vera-González, M. Renuncio-García, E.F. Vicente-Rabaneda, J.G. Ocejo-Vinyals, S. Castañeda, M.Á. González-Gay
DOI: https://doi.org/10.55563/clinexprheumatol/az2scd
I. Ferraz-Amaro, Z. Ibrahim-Achi, A. De vera-González, M. Renuncio-García, E.F. Vicente-Rabaneda, J.G. Ocejo-Vinyals, S. Castañeda, M.Á. González-Gay
DOI: https://doi.org/10.55563/clinexprheumatol/az2scd
CER18266
2025,43,8
Pg. 1431-1438
Free to view
Clinical characteristics and risk model of lower gastrointestinal involvement in systemic sclerosis
S. Xu, H. Huang, J. Zhou, M. Li, X. Zeng, H. Yang, D. Xu
DOI: https://doi.org/10.55563/clinexprheumatol/nhp9h9
S. Xu, H. Huang, J. Zhou, M. Li, X. Zeng, H. Yang, D. Xu
DOI: https://doi.org/10.55563/clinexprheumatol/nhp9h9
CER18057
2025,43,8
Pg. 1439-1445
Free to view
Fibroblast activities are associated with prolonged QTc and pulmonary arterial hypertension in patients with systemic sclerosis
C.T.H. Nielsen, S. Holm Nielsen, S. Søndergaard Korsholm, A.C.P. Diederichsen, J. Bonde, M.A. Karsdal, A.-C. Bay-Jensen, L.P. Diederichsen
DOI: https://doi.org/10.55563/clinexprheumatol/7didmb
C.T.H. Nielsen, S. Holm Nielsen, S. Søndergaard Korsholm, A.C.P. Diederichsen, J. Bonde, M.A. Karsdal, A.-C. Bay-Jensen, L.P. Diederichsen
DOI: https://doi.org/10.55563/clinexprheumatol/7didmb
CER18265
2025,43,8
Pg. 1446-1454
Free to view
Increased serum soluble interleukin-2 receptor concentrations are linked to high-sensitivity troponin T and disease progression in systemic sclerosis
L. Schumacher, A. Müller, A. Koch, R. Markewitz, P. Lamprecht, G. Riemekasten, S. Klapa
DOI: https://doi.org/10.55563/clinexprheumatol/re755k
L. Schumacher, A. Müller, A. Koch, R. Markewitz, P. Lamprecht, G. Riemekasten, S. Klapa
DOI: https://doi.org/10.55563/clinexprheumatol/re755k
CER18324
2025,43,8
Pg. 1455-1464
Free to view
Evaluation of the Coping Strategies Questionnaire-Revised for fatigue in systemic sclerosis: a Scleroderma Patient-centred Intervention Network (SPIN) cohort study
C. Dal Santo, M. Golberg, M.-E. Carrier, D. Harel, L. Kwakkenbos, S.J. Bartlett, C. Fortuné, A. Gietzen, K. Gottesman, G. Guillot, A. Lawrie-Jones, M. Richard, M. Worron-Sauvé, L. Mouthon, V.L. Malcarne, A. Benedetti, B.D. Thombs
Collaborator/s: C.E. Adams, C. Agard, L. Alric, M. André, F. Beaslay, E.J. Bernstein, S. Berthier, L. Bissonnette, S. Blaise, E. Bories, A. Bruns, C. Cacciatore, P. Carreira, M. Casadevall, B. Chaigne, L. Chung, B. Crichi, T. Deltombe, C.P. Denton, T. Desroche, R. Domsic, J.V. Dunne, B. Dunogue, R. Fare, D. Farge-Bancel, P.R. Fortin, T. Frech, L. Gauzère, A. Gerber, J.K. Gordon, B. Granel-Rey, A. Guffroy, G. Gyger, E. Hachulla, M. Hinchcliff, S. Hoa, M. Hughes, A. Ikic, S.R. Johnson, N. Khalidi, K.S. Lakin, M. Lambert, M. Larche, D. Launay, Y.C. Lee, P. Legendre, C. Leite, H. Maillard, N. Maltez, J. Manning, I. Marie, M. Martin Lopez, T. Martin, A. Masetto, A. Mekinian, S. Melchor Díaz, M. Mourguet, C. Nguyen, K. Nielsen, M. Nikpour, L. Olagne, V. Poindron, J. Pope, S. Proudman, G. Pugnet, L. Raffray, F. Rannou, A. Régent, F. Renou, S. Rivière, D. Robinson, E. Rodríguez Almazar, T.S. Rodriguez-Reyna, S. Roux, P. Smets, V. Sobanski, R.F. Spiera, V. Steen, E. Sutton, C. Thorne, D. Vagner, J. Varga, P. Wilcox, R.K. Wojeck, M. Cañedo Ayala, N. Co, V. Cook, T. Dal Santo, M. D'onofrio, S. Hu, E.-L. Nassar, M.A. Neyer, G. Pierson, S. Provencher
on behalf of the SPIN Investigators
DOI: https://doi.org/10.55563/clinexprheumatol/26zipq
C. Dal Santo, M. Golberg, M.-E. Carrier, D. Harel, L. Kwakkenbos, S.J. Bartlett, C. Fortuné, A. Gietzen, K. Gottesman, G. Guillot, A. Lawrie-Jones, M. Richard, M. Worron-Sauvé, L. Mouthon, V.L. Malcarne, A. Benedetti, B.D. Thombs
Collaborator/s: C.E. Adams, C. Agard, L. Alric, M. André, F. Beaslay, E.J. Bernstein, S. Berthier, L. Bissonnette, S. Blaise, E. Bories, A. Bruns, C. Cacciatore, P. Carreira, M. Casadevall, B. Chaigne, L. Chung, B. Crichi, T. Deltombe, C.P. Denton, T. Desroche, R. Domsic, J.V. Dunne, B. Dunogue, R. Fare, D. Farge-Bancel, P.R. Fortin, T. Frech, L. Gauzère, A. Gerber, J.K. Gordon, B. Granel-Rey, A. Guffroy, G. Gyger, E. Hachulla, M. Hinchcliff, S. Hoa, M. Hughes, A. Ikic, S.R. Johnson, N. Khalidi, K.S. Lakin, M. Lambert, M. Larche, D. Launay, Y.C. Lee, P. Legendre, C. Leite, H. Maillard, N. Maltez, J. Manning, I. Marie, M. Martin Lopez, T. Martin, A. Masetto, A. Mekinian, S. Melchor Díaz, M. Mourguet, C. Nguyen, K. Nielsen, M. Nikpour, L. Olagne, V. Poindron, J. Pope, S. Proudman, G. Pugnet, L. Raffray, F. Rannou, A. Régent, F. Renou, S. Rivière, D. Robinson, E. Rodríguez Almazar, T.S. Rodriguez-Reyna, S. Roux, P. Smets, V. Sobanski, R.F. Spiera, V. Steen, E. Sutton, C. Thorne, D. Vagner, J. Varga, P. Wilcox, R.K. Wojeck, M. Cañedo Ayala, N. Co, V. Cook, T. Dal Santo, M. D'onofrio, S. Hu, E.-L. Nassar, M.A. Neyer, G. Pierson, S. Provencher
on behalf of the SPIN Investigators
DOI: https://doi.org/10.55563/clinexprheumatol/26zipq
CER18329
2025,43,8
Pg. 1465-1471
Free to view
Association of serum myeloperoxidase with metabolic syndrome and adverse lipid profiles in scleroderma patients
I. Ferraz-Amaro, Z. Ibrahim-Achi, A. De vera-González, M. Renuncio-García, E.F. Vicente-Rabaneda, J.G. Ocejo-Vinjals, S. Castañeda, M.Á. González-Gay
DOI: https://doi.org/10.55563/clinexprheumatol/nuevmp
I. Ferraz-Amaro, Z. Ibrahim-Achi, A. De vera-González, M. Renuncio-García, E.F. Vicente-Rabaneda, J.G. Ocejo-Vinjals, S. Castañeda, M.Á. González-Gay
DOI: https://doi.org/10.55563/clinexprheumatol/nuevmp
CER18632
2025,43,8
Pg. 1472-1480
Free to view
Clinical and serological features of systemic sclerosis patients, according to different geographic areas: insights from an observational, cross-sectional study of two independent cohorts
V. Liakouli, H. Hamoud, M.I. Risha, M.E. Hanafy, A. Moshrif, R.A. Abdel-Magied, G.M. Omar, A.M. Elsayed, A. Elhefny, S. Mobasher, M. Abo Gabal, M. Hassanien, F.H. El Nouby, K. Abdelgalil, G. Forte, L. Navarini, P. Ruscitti, F. Ciccia, R. Giacomelli
DOI: https://doi.org/10.55563/clinexprheumatol/9bhd5d
V. Liakouli, H. Hamoud, M.I. Risha, M.E. Hanafy, A. Moshrif, R.A. Abdel-Magied, G.M. Omar, A.M. Elsayed, A. Elhefny, S. Mobasher, M. Abo Gabal, M. Hassanien, F.H. El Nouby, K. Abdelgalil, G. Forte, L. Navarini, P. Ruscitti, F. Ciccia, R. Giacomelli
DOI: https://doi.org/10.55563/clinexprheumatol/9bhd5d
CER18258
2025,43,8
Pg. 1481-1491
Free to view
Risk factors of cognitive function impairment in patients with systemic sclerosis
L. Krampek, F. Kiss, N. Farkas, R. Faludi, G. Nagy, A. Szabó, L. Czirják, C. Varjú
DOI: https://doi.org/10.55563/clinexprheumatol/isx6h8
L. Krampek, F. Kiss, N. Farkas, R. Faludi, G. Nagy, A. Szabó, L. Czirják, C. Varjú
DOI: https://doi.org/10.55563/clinexprheumatol/isx6h8
CER18741
2025,43,8
Pg. 1492-1498
Free to view
Impact of immunosuppression on development and outcome of systemic sclerosis-associated pulmonary arterial hypertension
S. Rodolfi, C.C.M. Ng, A.M. Ruiz Bejerano, M. Kanitkar, V.H. Ong, C.P. Denton
DOI: https://doi.org/10.55563/clinexprheumatol/x0keg5
S. Rodolfi, C.C.M. Ng, A.M. Ruiz Bejerano, M. Kanitkar, V.H. Ong, C.P. Denton
DOI: https://doi.org/10.55563/clinexprheumatol/x0keg5
CER18923
2025,43,8
Pg. 1499-1507
Free to view
Evaluation of different algorithms to identify the scleroderma pattern in nailfold videocapillaroscopy
A. Shinzato, J.Y. Sekiyama, C. Kayser
DOI: https://doi.org/10.55563/clinexprheumatol/0igmnr
A. Shinzato, J.Y. Sekiyama, C. Kayser
DOI: https://doi.org/10.55563/clinexprheumatol/0igmnr
CER18904
2025,43,8
Pg. 1508-1515
Free to view
Hopelessness is associated to severity of both digital vasculopathy and lung disease in systemic sclerosis patients: a prospective one-year study
P. Bearzi, L. Navarini, L. Capra Mattioli, G. Bindi, M. Minerba, C. Salvolini, A. Orlando, G. Lanaia, M. Vizzini, T. Cocchiaro, M. Vomero, O. Berardicurti, D. Currado, V. Liakouli, A. Marcoccia, R. Giacomelli
DOI: https://doi.org/10.55563/clinexprheumatol/cp6fec
P. Bearzi, L. Navarini, L. Capra Mattioli, G. Bindi, M. Minerba, C. Salvolini, A. Orlando, G. Lanaia, M. Vizzini, T. Cocchiaro, M. Vomero, O. Berardicurti, D. Currado, V. Liakouli, A. Marcoccia, R. Giacomelli
DOI: https://doi.org/10.55563/clinexprheumatol/cp6fec
Review
CER18104
2025,43,8
Pg. 1516-1526
Free to view
The burden of illness of the organ manifestations of systemic sclerosis: a pragmatic, targeted review
V. Smith, Z. Marjenberg, E.R. Volkmann
DOI: https://doi.org/10.55563/clinexprheumatol/ey5nhr
V. Smith, Z. Marjenberg, E.R. Volkmann
DOI: https://doi.org/10.55563/clinexprheumatol/ey5nhr
Letters to the Editor
CER18086
2025,43,8
Pg. 1527-1528
Free to view
Severe lung damage in anti-RNPC-3 antibody-positive patients: expanding the spectrum beyond systemic sclerosis
Y. Yamano, Y. Muro, H. Koizumi, M. Akiyama, T. Kimura, Y. Kondoh
DOI: https://doi.org/10.55563/clinexprheumatol/5o45p1
Y. Yamano, Y. Muro, H. Koizumi, M. Akiyama, T. Kimura, Y. Kondoh
DOI: https://doi.org/10.55563/clinexprheumatol/5o45p1
CER18071
2025,43,8
Pg. 1529
Free to view
Is there evidence for an autoimmune response to components of the TGF-β signalling pathway in scleroderma?
R. Wallwork, L. Casciola-Rosen, F.M. Wigley
DOI: https://doi.org/10.55563/clinexprheumatol/rp5hev
R. Wallwork, L. Casciola-Rosen, F.M. Wigley
DOI: https://doi.org/10.55563/clinexprheumatol/rp5hev
CER18840
2025,43,8
Pg. 1530-1531
Free to view
The use of JAK-1 selective inhibitor filgotinib to manage a rare case of concurrent cervical spine calcinosis and inflammatory changes of the odontoid process in diffuse cutaneous systemic sclerosis
E. Capparelli, E. Zaccara, D. Bompane, L. Castelnovo, A. Tamburello, P. Faggioli
DOI: https://doi.org/10.55563/clinexprheumatol/19pb94
E. Capparelli, E. Zaccara, D. Bompane, L. Castelnovo, A. Tamburello, P. Faggioli
DOI: https://doi.org/10.55563/clinexprheumatol/19pb94